Uzbekistan Pharmaceuticals & Healthcare Report Q4 2013 - New Market Research Report
As the most populous state in Central Asia, with a population expected to increase to 29.8mn by 2017, we expect interest in the pharmaceutical and healthcare markets to increase. However, Uzbekistan has a number of obstacles to overcome before it will present an attractive prospect to potential investors.
View full press release